Aimei Health Technology Co., Ltd (AFJK) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Shell Companies industria. La empresa tiene su sede en New York City, NY, United States. El CEO actual es Junheng Xie.
AFJK tiene fecha de IPO 2024-01-22, 2 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $313.43M.
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
